GoHealth, Inc. (NASDAQ:GOCO) Receives Consensus Recommendation of “Hold” from Analysts

GoHealth, Inc. (NASDAQ:GOCO) has earned a consensus recommendation of “Hold” from the five brokerages that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a strong buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $5.00.

Several equities analysts have issued reports on the company. Noble Financial upgraded GoHealth to a “strong-buy” rating in a research report on Wednesday, April 1st. Weiss Ratings reiterated a “sell (e+)” rating on shares of GoHealth in a research report on Monday, December 29th. Finally, Freedom Capital cut GoHealth from a “strong-buy” rating to a “hold” rating in a research report on Monday.

Hedge Funds Weigh In On GoHealth

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Bank of America Corp DE boosted its holdings in shares of GoHealth by 22.8% in the 4th quarter. Bank of America Corp DE now owns 7,831 shares of the company’s stock valued at $105,000 after purchasing an additional 1,452 shares during the last quarter. Empowered Funds LLC raised its position in GoHealth by 7.7% in the first quarter. Empowered Funds LLC now owns 25,008 shares of the company’s stock valued at $307,000 after purchasing an additional 1,790 shares during the period. Bridgeway Capital Management LLC raised its position in GoHealth by 8.2% in the second quarter. Bridgeway Capital Management LLC now owns 27,066 shares of the company’s stock valued at $150,000 after purchasing an additional 2,058 shares during the period. Geode Capital Management LLC raised its position in GoHealth by 4.3% in the second quarter. Geode Capital Management LLC now owns 118,961 shares of the company’s stock valued at $660,000 after purchasing an additional 4,955 shares during the period. Finally, Barclays PLC raised its position in GoHealth by 10.1% in the fourth quarter. Barclays PLC now owns 81,181 shares of the company’s stock valued at $175,000 after purchasing an additional 7,430 shares during the period. Institutional investors and hedge funds own 24.21% of the company’s stock.

GoHealth Stock Down 1.2%

GOCO opened at $1.26 on Tuesday. The business has a 50 day moving average price of $1.71 and a two-hundred day moving average price of $2.74. The company has a market cap of $36.17 million, a PE ratio of -0.07 and a beta of 1.61. GoHealth has a 52 week low of $1.22 and a 52 week high of $11.36.

GoHealth (NASDAQ:GOCO) last announced its quarterly earnings data on Tuesday, March 31st. The company reported ($1.03) EPS for the quarter, beating analysts’ consensus estimates of ($2.69) by $1.66. GoHealth had a negative net margin of 26.95% and a positive return on equity of 8.00%. The firm had revenue of $12.64 million during the quarter, compared to the consensus estimate of $88.62 million. As a group, sell-side analysts expect that GoHealth will post -5.5 EPS for the current fiscal year.

About GoHealth

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.